Enveric Biosciences Inc logo

Enveric Biosciences Inc

$ 3.09 +0.02 (+0.65%) 10:08 PM EST
P/E:
At Loss
P/B:
0.28
Market Cap:
$ 6.42M
Enterprise V:
$ -14.69M
Volume:
23.82K
Avg Vol (2M):
58.37K
Also Trade In:
Volume:
23.82K
Market Cap $:
6.42M
PE Ratio:
At Loss
Avg Vol (2-Month):
58.37K
Enterprise Value $:
-14.69M
PB Ratio:
0.28
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN).
Name Current Vs Industry Vs History
Cash-To-Debt 238.21
Equity-to-Asset 0.74
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -3.56
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 50.24
9-Day RSI 45.39
14-Day RSI 42.37
6-1 Month Momentum % -63.1
12-1 Month Momentum % -95.01

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.57
Quick Ratio 8.57
Cash Ratio 8.16

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -325.5

Financials (Next Earnings Date:2023-02-15 Est.)

ENVB's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ENVB

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -96.55
Beta 0.58
Volatility % 70.35
14-Day RSI 42.37
14-Day ATR ($) 0.269058
20-Day SMA ($) 3.14925
12-1 Month Momentum % -95.01
52-Week Range ($) 2.61 - 73.5
Shares Outstanding (Mil) 2.08

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Enveric Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Enveric Biosciences Inc Analysis

Share your research

Headlines

See More
No news.